Atlas Trials

Post-Market Clinical Follow-up Performance and Safety Study of Etermis 3 and 4 in the Face

Clinical trial NCT04210258 · COMPLETED

Trial details

NCT number
NCT04210258
Sponsor
Merz Pharmaceuticals GmbH
Status
COMPLETED
Study type
OBSERVATIONAL
Correction of Facial Wrinkles/FoldsFacial Volume Enhancement
Start date
2016-06-01
Primary completion
2017-12-27
Enrollment
154

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.